GENPACT LIMITED
GGenpact Limited (G) is a global professional services firm specializing in digital transformation, business process management, and consulting services. Founded in 1997, it focuses on delivering automation, analytics, and industry-specific solutions to help organizations improve operational efficiency and drive growth across various sectors, including finance, healthcare, manufacturing, and more.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 23, 2025 | $0.17 | 2025-12-09 | 2025-12-09 |
| September 25, 2025 | $0.17 | 2025-09-11 | 2025-09-11 |
| June 30, 2025 | $0.17 | 2025-06-18 | 2025-06-18 |
| March 26, 2025 | $0.17 | 2025-03-11 | 2025-03-11 |
| December 23, 2024 | $0.15 | 2024-12-09 | 2024-12-09 |
Dividends Summary
- Consistent Payer: GENPACT LIMITED has rewarded shareholders with 44 dividend payments over the past 21 years.
- Total Returned Value: Investors who held G shares during this period received a total of $7.42 per share in dividend income.
- Latest Payout: The most recent dividend of $0.17/share was paid 31 days ago, on December 23, 2025.
- Yield & Schedule: G currently pays dividends quarterly with an annual yield of 1.47%.
- Dividend Growth: Since 2004, the dividend payout has grown by 4.6%, from $0.16 to $0.17.
- Dividend Reliability: G has maintained or increased its dividend for 36 consecutive payments.
Company News
The North America Business Process Outsourcing market is projected to grow from $112.96 billion in 2024 to $211.73 billion by 2033, driven by technological advancements, cost-saving needs, and digital transformation across industries.
Genpact announced a quarterly cash dividend of $0.17 per common share, payable on December 23, 2025, to shareholders of record as of December 9, 2025.
Genpact Limited, a global advanced technology services and solutions company, announced that its board of directors has declared a cash dividend of $0.17 per common share for the second quarter of 2025.
The global regulatory affairs outsourcing market is expected to grow significantly from 2024 to 2030, driven by the globalization of biopharmaceutical and medical device companies and the need for specialized regulatory expertise. Technological advancements in regulatory processes are also shaping the market.
The Industrial Services Market is projected to grow from $35.47 billion in 2023 to $65.76 billion by 2032, driven by the increasing adoption of Industry 4.0 technologies like IoT, AI, and advanced analytics in industrial systems.
